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Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Molecular Toxinology – Cloning Toxin Genes for 
Addressing Functional Analysis and  
Disclosure Drug Leads 
Gandhi Rádis-Baptista 
Institute of Marine Sciences, Federal University of Ceará 
Brazil 
1. Introduction 
The revolution in Biology started earlier with the genetic works of Gregor Mendel (1866), 
who, through his work with pea breeding, observed the phenomena of dominance and 
segregation of traits and discovered several laws of heredity.  The pioneered endeavor of 
deciphering the linkage between transmission of heredity and a biomolecule was succeeded 
by the works of Griffith (1928), Oswald Avery, Colin McLeod, and Marylin McCarty (1944), 
who demonstrated that the instruction for virulence traits in bacteria was contained in the 
deoxyribonucleic acid (DNA) molecule, as well as Alfred Hershey and Martha Chase (1952), 
who elegantly proved that the progeny of bacteriophage is propagated after the injection of 
the bacteriophage’s genetic material into the host cell.  The hallmark of molecular biology 
arose in 1953 with the description of the double-helix backbone of DNA by James Watson 
and Francis Crick, who also described that such a structure may suggest a mechanism of 
DNA replication (Watson and Crick, 1953). Notably, the deduction of the DNA structure 
was based on the data of other works by Erwin Chargaff, who determined the base 
correspondence and ratios in nucleic acid, and by Rosalind Franklin, who obtained DNA 
fiber images from X-ray diffraction.  The elegant genetic experiments from François Jacob 
and Jacques Monod (1961) established the concept of cis-acting elements and the mechanism 
by which the operator and repressor regulate β-galactosidase expression in Escherichia coli 
and sugar metabolism (Jacob and Monod, 1961). At same time, Marshal Nirenberg was 
leading the race to decipher the genetic code (Nirenberg, 2004). By the 1970s, Fred Sanger 
and Walter Gilbert developed two distinct methodologies for DNA sequencing, which 
culminated with automated high-throughput DNA sequence analysis, thus opening the 
door for the genomic revolution and the publication of hundred of genomes, including the 
human genome. The central dogma of molecular biology, which postulated that DNA 
directs its own replication and its transcription to yield RNA, which in turn directs its 
translation to form protein, was wisely proposed by F. Crick in 1958 (Crick, 1970). This also 
included the “probable transference of information”, which we know now as RNA 
replication and reverse transcription, after the seminal works of D. Baltimore (1970) and J.M. 
Bishop on the molecular virology of retroviruses and oncogenes (1973). The ‘biological 
revolution’ continued forward with important discoveries such as the mechanism by which 
chromosomes are protected at their ends (the telomeres) against degradation and the 
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involvement of the enzyme (telomerase) that forms these ends by Elizabeth H. Blackburn, 
Carol W. Greider, and Jack W. Szostaktelomere (Blackburn, 2005) as well as the novel 
mechanism of gene regulation mediated by double-stranded RNA (interference RNA) that 
triggers suppression of gene activity by Andrew Z. Fire and Craig C. Mello (Mello and 
Conte, 2004; Fire, 2007). Most of these scientific conquests have been nicely compiled in the 
writing of Lander and Weinberg (2002), where the initial events of the Biological Revolution 
are outlined in more detail. Other actors have played a significant role in the field, but a 
review of this short time frame of scientific conquests may give us a taste of how the field of 
molecular biology experienced periods of excitement and ‘epic’ concretizations, culminating 
with what we know today. New avenues are being explored with the advent of two new 
disciplines that incorporate paradigmatic concepts and approaches to interrogate the 
complexity of life, namely, systems biology and synthetic biology. In the first case, the focus 
is on the analysis of complex biological systems from a holistic point of view, i.e., to study 
how individual genes and proteins interact to build entire organisms (single cell or 
multicellular) and allow them to operate properly. In the field of synthetic biology, 
principles of engineering are used to build from scratch living systems able to perform 
alternative functions not found in nature (Bader, 2011). 
Currently, recombinant DNA technology and DNA cloning represent an indispensable tool 
box for the research of distinct life science fields as diverse as environmental science, 
evolutionary biology, cell biology, microbiology, molecular medicine and pharmacology, 
and structural and systems biology. 
A particular field of interest that involves recombinant DNA technology and covers the 
study of ecological, biochemical, pharmacological and structural aspects of animal toxins is 
referred to in the scientific community as Molecular Toxinology.  From an ecological point 
of view, animal venom might be considered an arsenal of organic and protein substances 
capable of immobilizing the competitor or prey by interfering with specific molecular 
targets in their cells and tissues. Therefore, animals equipped with venom glands and an 
inoculating apparatus have a significant fitness advantage. Biochemically and 
pharmacologically, chemical and protein diversities correlate with biodiversity, i.e., diverse 
indigenous animals inhabiting a given biome may offer novel compounds and bioactive 
molecules. Before the advent of molecular cloning and recombinant DNA technology, only 
the major components of venom were purified in high yield using protein chemistry 
techniques suited for functional characterization. Consequently, milligrams of purified toxin 
were required for studies by classical tissue-based assays, which limited the analysis of toxin 
biological activity to the molecular level. However, with the refinement of instrumentation 
in the context of ‘omics’ (e.g., genomics, transcriptomics, proteomics, and interactomics), 
toxins expressed in the venom even in minute amounts could be thoroughly examined.   
In this chapter, I wish to introduce some selected molecular biology techniques that can be 
applied to investigate the diversity of polypeptide molecules present in animal venoms. 
2. Animal venom peptides and proteins as therapeutics 
The global market for peptide and protein therapeutics was valued at over US$ 57 Billion in 
2006 and estimates suggest that it will grow continuously in the next years at a 9.7% 
compound annual growth rate (CAGR) and reach a value of $103 billion by 2014 (Nair, 
2011). According to these analyses, there is a high demand in the therapeutic proteins 
market for engineered monoclonal antibodies (MAb), insulins, cytokines, interferons and 
www.intechopen.com
Molecular Toxinology – Cloning Toxin Genes  
for Addressing Functional Analysis and Disclosure Drug Leads 
 
163 
related immune modulators, enzymes, hematopoietic growth factors (erythropoietins) and 
coagulation factors. These polypeptide drugs are designed for the treatment of autoimmune 
and cardiovascular diseases, diabetes and cancer.  The increasing demanding for therapeutic 
polypeptides is due in part to the excellent affinity and selectivity for the disease target 
displayed by such molecules, as well as biological compatibility. Currently, therapeutic 
peptides and proteins are manufactured by means of synthetic peptide chemistry and 
recombinant technology, respectively.  Consequently, polypeptide drugs offer unparalleled 
opportunities for innovation in molecular design, improved pharmacokinetics, and disease 
target-delivery of therapeutics.  
Animal venom is a collection of molecules selected during millions of years of metazoan 
evolution with which specific tissue and target preferences are invariably observed among 
numerous families of toxins. In fact, snakes (Birrel et al., 2007), scorpions (Bringans et al., 
2008), spiders (Estrada et al., 2007), and sea snails (Becker et al., 2008), to name just a few, 
produce and secrete a valuable diversity of toxins capable of interacting with distinct 
molecular targets within the cells of their prey or victims. Importantly, from the point of 
view of molecular evolution and medical biotechnology, using phylogenetic analysis, Fry 
(2005) inferred that polypeptide toxins secreted in a given venom evolved from endogenous 
bioactive protein genes, which were expressed early in tissues other than venom glands. For 
example, snake venom three finger toxins (3FTs) appear to have evolved from a common 
protein ancestor, such as the nicotinic acetylcholine receptor-binding LYNX, which is 
expressed in large projection neurons in the hippocampus, cortex and cerebellum.  Other 
toxins that were related to ancestral proteins, for which the genes were preserved during the 
evolution of snake venom gland, include acetylcholinesterases, 
disintegrins/metalloproteinases, C-type lectins, complement C3, crotasin/defensin-like 
peptides, cystatins, endothelins, factor V, factor X, kallikrein, kunitz-type protease 
inhibitors, LYNX/SLUR, L-amino oxidase, natriuretic peptides/bradykinin potentiating 
peptides, nerve growth factor, phospholipase A2, and vascular endothelial growth factor.  
Considering the evolutionary conservation of polypeptides toxins and the excellent market 
opportunity for use a therapeutic peptide and proteins, animal toxins represent one unique 
source of ready-to-use engineered polypeptides capable of modulating vital human 
physiological and pathological processes. Numerous examples of the use of animal toxin in 
medicine have been reported. In their articles “Bugs as Drugs” (part I and II), E. P. 
Cherniack (2010; 2011) reviews the use of a number of different ‘bugs’ (worms, leeches, 
snail, ticks, centipedes, spider) and their metabolic products (endogenous or secreted) in 
medicine and describes the clinical benefits of such biological/pharmacological resources. 
As a particular biological effect is the result of a combination of a specific activity 
intrinsically contained in a single molecule, a myriad of new pharmacologically active 
compounds can be isolated from animal venom. For example, a dozen snake venom toxins 
belonging to several protein families such as C-type lectin, metalloprotease, phospholipase 
A2, and three-finger toxin display anticoagulant activities and a high potential for 
therapeutic use in preventing pathological clot formation (Kini, 2006). The snake venom 
components that act on the vertebrate blood coagulation cascade can be categorized, 
depending on their hemostatic action, as follows:  enzymes that clot fibrinogen; enzymes 
that degrade fibrin (ogen); plasminogen activators; prothrombin activators; factor V 
activators; factor X activators; anticoagulants (inhibitors of prothrombinase complex 
formation, inhibitors of thrombin, phospholipases, and protein C activators); enzymes with 
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hemorrhagic activity; enzymes that degrade plasma serine proteinase inhibitors; and 
platelet aggregation inducers (direct acting enzymes, direct acting non-enzymatic 
components, and inhibitors of platelet aggregation) (Markland, 1998). Some of these toxins 
have been clinically used as therapeutics or diagnostic reagents, while others are under pre-
clinical trials (Fox and Serrano, 2007). For example, Exendin-4, a 39-amino acid peptide from 
the saliva of the lizard Heloderma suspectum, is able to improve blood sugar control in adults 
with type 2 diabetes mellitus, and it has been commercially registered as Byetta® 
(Exenatide). Furthermore, a number of toxins isolated from aquatic (including marine) and 
terrestrial animals represent the ultimate resource of novel molecules to treat highly 
prevalent cardiovascular diseases, such as high blood pressure and arrhytmias (Hodgson & 
Isbister, 2009), human neurological disturbances (Mortari et al., 2007), and cancer (Molinski 
et al., 2009). In fact, some of the best selling drugs used to treat high blood pressure, namely 
captopril and analogues, which act by inhibiting the angiotensin converting enzyme (ACE), 
were developed using a rational chemical synthesis approach using a pentapeptide toxin 
expressed in the venom of the Brazilian pit viper Bothrops jararaca as a model (Ferreira, 1965; 
1985; Ondetti et al., 1977; Cushman and Ondetti; 1991). The therapeutic potential of venom 
peptides have also been investigated with regards to their pharmacology effects on ion 
channels and neural receptors (Lewis and Garcia, 2003). For example, an N-type voltage-
sensitive calcium channel blocker peptide, isolated from the marine mollusk Conus (Conus 
magus), was recently approved by the US Food and Drug Administration as a drug 
(ziconotide/ Prialt®) for the treatment of severe chronic pain (Schmidtko et al., 2010).  
To study the mechanistic specificities of a given toxin toward a molecular target, milligrams 
of pure polypeptides are usually required, which is not always easy to obtain from certain 
venomous animals. This is particularly true for purified molecules from the venom and 
saliva of small creatures such as scorpions, spiders, wasps, poison worms, and 
hematophagous animals.  Consequently, a powerful approach used to investigate the 
therapeutic potential of animal venoms is based on proteomics and molecular cloning 
techniques. Information about proteomic-based characterization of animal venom 
(venomics) can be found elsewhere (Calvete et al., 2007; 2009; Escoubas et al., 2008; 2009). 
This chapter reviews select topics on molecular toxinology, which include not only the 
cloning and recombinant expression of a single toxin but also the receptor-guided high-
throughput screening of polypeptide venom libraries. 
2.1 Molecular cloning of animal toxin genes  
DNA cloning, or molecular cloning, is the process of constructing recombinant DNA 
molecules, transferring them in a given host cell and making copies of the inserted DNA, 
usually genes or the product of their transcription, i.e., messenger RNAs (Watson et al., 
2008).  For cloning, all that is necessary for propagation of cloned DNA is the piece of DNA 
of interest (i.e., insert DNA) from a particular source, a vector (small molecule of DNA 
capable of self-replication and containing a selectable marker), and restriction and 
modifying enzymes used to cut and join the insert and vector DNA together. Once 
recombinant DNA molecules are prepared in vitro, a host cell, usually Gram-negative 
bacteria Escherichia coli is transformed with the engineered vector and propagated millions 
of times to produce large quantities of cloned DNA. When a collection of thousands of 
DNA sequences is cloned instead of a single piece of DNA, it is referred to as a library.  
Essentially, two main types of libraries have been prepared and utilized in toxin research: 
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complementary or copied DNA (cDNA) and genomic libraries. The cDNA library is 
designed to represent the transcriptome, i.e., the pool of messenger RNAs (mRNA) 
molecules that is produced by a cell type, tissue or organ in given time or metabolic 
condition. Therefore, it represents a snapshot of cell status, even if some transcripts 
(mRNAs) may be constitutively expressed. Thus, libraries of cDNAs or expressed sequence 
tags (ESTs) can be highly useful when the focus of a particular research project encompasses 
interrogative studies of gene expression profiles or differential gene expression. Using 
cDNA and EST sequencing, the gene expression profiles of the venom glands from several 
species of poison animals have been analyzed, including snakes (Zhang et al., 2006; 
Wagstaff and Harrison, 2006; Pahari et al., 2007; Cassewell et al., 2009; Neiva et al., 2009; 
Georgieva et al., 2010; Durban et al., 2011; Jiang et al., 2011, Rokyta et al., 2011), scorpions 
(Schwartz et al., 2007; Ma et al., 2009; Ruiming et al., 2010; Morgenstern et al., 2011), spiders 
(Chen et al., 2008 Fernandes-Pedrosa et al., 2008; Gremski et al., 2010; Jiang et al., 2010), 
platypus (Whittington et al., 2099; 2010), conus (Pi et al., 2006; Hu et al., 2011), and jellyfish 
(Yang et al., 2003). 
Differential gene expression of venom gland libraries has been used to investigate the 
molecular diversity of venom polypeptides. For example, Morgenstern and collaborators 
(2011) have reported that a significant difference exists in the transcriptome of resting 
venom glands from the buthid scorpion Hottentotta judaicus in comparison with the gland 
that is actively engaged in regenerating its venom. The transcriptome profile of a replete 
(resting) venom gland is rich in low-abundance toxin transcripts and tends to 
predominantly consist of open reading frame (ORF) sequences encoding toxins acting on 
voltage- and calcium-activated potassium ion channels. To perform such a study, a cDNA 
library was prepared from the venom gland of scorpions that had not been milked or 
induced to produce venom and was then compared with a cDNA library prepared from the 
venom gland of milked specimens in which the venom glands were committed to 
replenishing the venom pool of transcripts and toxins. This technique, termed cDNA 
subtraction, which will be described in the next section, and the resulting subtracted cDNA 
library,  are generally used for the screening of cDNAs corresponding to mRNAs 
differentially expressed or regulated.  The differential pattern of transcripts in resting and 
regenerating venom glands revealed an important aspect to be considered when studying 
transcriptomes of venomous animals and suggests which strategy should be taken into 
account to prepare cDNA libraries. In practical terms, most cDNA libraries are prepared 
after milking the venom from poisonous animals to empty the venom gland and induce the 
synthesis of total RNA prior to mRNA purification (Rottenberg et al., 1971; Rádis-Baptista, 
1999). Thus, by examining full or subtracted cDNA libraries, as exemplified for scorpion 
venom glands, qualitative and quantitative differences are detected, particularly when one 
wishes to know the constitutive or induced venom transcriptomes for comparison with the 
corresponding proteomes (Ma et al., 2010). In fact, a combination of transcriptome analysis, 
i.e., cDNA sequencing, with mass spectrometry represents a useful alternative to 
characterize the animal venom, as was utilized for Cone marine snail venom analysis, and 
compare the inter- and intra-species variation that exists among venom peptide libraries 
(Gowd et al., 2008).  
In molecular toxinology, the data obtained from genomic DNA library analysis seems, at 
first glance, less informative than those obtained from cDNA libraries due to the relative 
static nature of genomes. However, genomic libraries provide information about gene 
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number, diversity and organization. For example, using a PCR homology screening method, 
a crotamine paralogous toxin gene, crotasin, which is 2.5 kilobase (kb) long and organized in 
three exons intervened by two introns, was identified in a rattlesnake genomic DNA 
bacteriophage library; this suggested that gene duplication and accelerated independent 
evolution operated in the diversification of crotamine/crotasin genes (Rádis-Baptista et al., 
2004). Such phenomena of gene evolution is a recurrent theme in toxinology (Kordis and 
Gubensek, 2000; Fry et al., 2009) and genomic libraries configure a good technical resources 
to retrieve such informations. Genomic DNA libraries constructed in bacterial artificial 
chromosomes (BACs) for Bungarus multicinctus and Naja naja, two old world toxic elapid 
snakes, were screened with probes for four major families of toxins, three-finger toxin 
(3FTx), phospholipase A2 (PLA2), Kunitz-type protease inhibitor (Kunitz) and natriuretic 
peptide (NP), and results showed 3FTx as the major toxin gene in elapidae venom (Jiang et 
al., 2011). These 3FTx genes are also composed of three exons and two introns in a region of 
approximately 2.5 kb (Tamiya and Fujimi, 2006), and they were shown to represent five 
putative tandem duplicates in B. multicinctus and seven in N. atra, thereby suggesting that 
tandem duplications has also contributed to the expansions of toxin multigene families in 
these two elapids (Jiang et al., 2011). Interesting, genome analysis of platypus 
(Ornithorhynchus anatinus) coupled with the transcriptome of its venomous apparatus 
revealed 83 novel putative platypus venom genes, distributed among 13 toxin families, 
which are homologous to known toxins from a wide range of vertebrates (fish, reptiles, 
insectivores) and invertebrates (spiders, sea anemones, starfish). A number of these 
platypus venom toxin families are expressed in tissues other than the venom gland, as 
observed earlier with snake venom toxins (Whittington et al., 2010). 
A glimpse into the realm of molecular toxinology reveals that recombinant DNA technology 
is essential for the analysis of the complex pharmacological effects of venom toxins and their 
potential biomedical and clinical applications. In the next section, the current and potential 
molecular techniques used for investigating toxins in a high-throughput manner are 
described in further detail. 
2.1.1 Construction of a venom gland cDNA library  
The basic steps for constructing a cDNA library include the following: (1) excision of venom 
glands from the poisonous animal of interest, (2) preparation of total and messenger RNA 
for cDNA cloning, (3) synthesis of cDNA from mRNA by reverse transcription, (4) selection 
of a vector, plasmid or bacteriophage (phage) for cloning and propagation of cDNA 
libraries, (5) sequencing of all cDNA libraries or screening for desired clones before 
sequence analysis, and (6) validation of cDNA clones for functional analysis. Synthesis kits 
for convenient construction of cDNA libraries are commercially available, and detailed 
information of a particular system can be obtained from sales representatives at companies 
such as Clontech Laboratories, Inc (Mountain View, CA-U.S.A.) and Stratagene (presently, 
Agilent Technologies, Inc., Santa Clara, CA-U.S.A.). 
Total RNA is typically purified from the tissue of choice, from which the sequences of 
interest are more abundant, using the single-step acid guanidinium thiocyanate-phenol-
chloroform method of Chomczynski and Sacchi (1987), by which cells are quickly disrupted, 
their components are solubilized, and the endogenous RNase is simultaneously denatured 
using guanidinium salt. Although such methods of RNA extraction and purification are 
very effective and reliable, caution should be taken when the sources of RNA extraction are 
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tissues rich in lipids, polysaccharides and proteoglycans. In such cases, modification of the 
method, such as by introducing an organic extraction step and changing in the condition of 
RNA precipitation, can counteract the interference of these contaminants that would 
otherwise inhibit reactions of reverse-transcription. Total RNA purified by this single-step 
method is not only used for mRNA - or poly(A)+ RNA - purification and for cDNA synthesis 
but also for applications such as northern hybridization, RNase protection assay and 
dot/slot blotting (Sambrook and Russel, 2001). In general, tissues such as snake venom 
glands and sea anemone tentacles yield between 3 and 10 µg/mg of RNA. Once the total 
RNA has been purified, the quality and integrity must be analyzed. The quality is assessed 
spectrophotometrically by analyzing the A260/A280 ratio, which should be between 1.8 and 
2.0. RNA quality is confirmed by running an aliquot of total RNA preparation using 
denaturing formaldehyde agarose gel electrophoreses (stained with ethidium bromide) to 
observe the ratio of 28S and 18S ribosomal RNA. The theoretical 28S:18S ratio for eukaryotic 
RNA is approximately 2:1, but this ratio might be different with RNA extracted from tissues 
of other organisms. An alternative to denaturing formaldehyde agarose gel electrophoresis 
is the analysis of total RNA in a microfluidic device, by which RNA integrity and 
concentration are automatically assessed. However, as it is more convenient and less 
laborious and inexpensive, gel-based analysis of total RNA quality can be still useful, when 
formamide is used with RNA samples and TAE agarose gel instead of formaldehyde as 
denaturing agent (Masek et al., 2004).  
Traditionally, cDNA libraries are prepared using mRNA, and not total RNA, to promote the 
reaction of reverse transcription. Thus, methods of preparing high-quality mRNA should be 
applied. These methods are based on the presence a 3' end polyadenosine tail found in most 
eukaryotic mRNAs.  Short oligonucleotides of deoxythymidine (18 to 30 nucleotides in 
length) - oligo(dT)18-30, immobilized on cellulose or linked to biotin, form a stable hybrid 
with the poly(A)+ tail of mRNA in the presence of a high concentration of salt. The 
polyadenylated RNAs are denatured (at 70-72ºC for 5-10 min), allowed to hybridize with the 
oligo(dT) and separated by affinity (column chromatography) or captured (with 
streptavidin-coated paramagnetic beads) from the other RNAs (ribosomal RNA, transfer 
RNA), which are washed away, and the RNA is eluted with a low-salt buffer. The poly(A)+ 
RNA pool is quantified by ultraviolet (UV) spectrophotometry and then used for cDNA 
synthesis. It is important to note that only 1 to 5% of total RNA constitute poly(A)+ RNA, 
and RNAs that represent less than 0.5% of the total mRNA population of the cell are 
referred as ‘rare’ mRNAs. Therefore, when a cDNA library is being prepared, it should be 
comprehensive enough to include clones that represent ‘low abundance’ or ‘rare’ 
transcribed sequences (mRNAs). This is estimated the following formulas:  
N= ln (1 - P)/ln (1-[1/n]), 
where N is the number of clones required, P is the probability (usually 0.99), and 1/n is the 
fraction of the total mRNA that is represented by a single type of rare mRNA (Sambrook 
and Russel, 2001). 
Or,  q = 1 – P = [1 - (n/T)]B 
where n is the number of molecules of the rarest mRNA in a cell and T is the total number of 
mRNA molecules in a cell. The desired base (B) is the number of clones that should be screened 
to achieve a 99% probability that a cDNA clone will exist in the library (Ausubel et al., 1998).  
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Often, when 500,000 to 1,000,000 independent cDNA clones are present in an unamplified 
library, at least one copy of every mRNA should be present in the library. In more practical 
terms, to obtain a representative cDNA library with a high probability of finding a clone 
harboring a rare transcribed sequence, 1 to 5 µg (or less) of poly(A)+ mRNA is usually 
sufficient. 
To synthesize cDNAs, commercially available RNA-dependent DNA polymerases (reverse 
transcriptase, RT), derived from avian or murine retroviruses, catalyze the addition of 
deoxyribonucleotides to the 3’-hydroxyl terminus of a primed RNA-DNA hybrid, for which 
a deoxyoligonucleotide, such as an oligo(dT), a pool of random hexamers or a specific 
sequence, is used as a primer and the mRNA is used as template. This action of extension is 
referred to as reverse transcriptase 5’→3’ DNA polymerase activity, and the product is a 
hybrid molecule composed of a single-stranded RNA (the mRNA) and a single-stranded 
cDNA (ss-cDNA). The non-engineered RTs have two additional catalytic activities and are 
consequently multifunctional enzymes. These RTs display a low level of DNA polymerase 
activity but a considerable 3’→5’ or 5’→3’ exonuclease processivity of RNA degradation in 
an RNA:DNA hybrid, or RNase H activity (Ausubel et al., 1998). Although the RNase H 
activity of RTs is useful in molecular biology (e.g., selective destruction of parts of an RNA 
molecule), it has been eliminated from most recombinant engineered enzymes 
commercialized for research to avoid the degradation of an mRNA template and improve 
the yield of synthetic cDNA.  It is important to understand the mechanism by which RT 
functions, given the final product of this step. ss-cDNA is a useful starting material for other 
specific techniques of cloning, such as 3’- and 5’-RACE (rapid amplification of cDNA ends), 
reverse transcription coupled with PCR (RT-PCR), and quantitative real-time PCR (qPCR).  
One critical step in the preparation of ds-cDNA for cloning is the choice of primers for 
synthesis of first-strand cDNA. Primers used for cDNA synthesis include (1) oligo (dT), a 12-
18 nucleotide oligo that binds to the poly(A) tail at the 3’ end of mRNA; (2) primer-adaptors 
that contain a homopolymeric tract at the 3’ end and a restriction site; (3) primers linked to a 
plasmid; and (4) random primers (Sambrook and Russel, 2001). However, the most popular 
methods for cDNA library construction are based on priming cDNAs with an oligo(dT) 
adaptor for directional cloning and homopolymeric priming of second-strand cDNA; this 
latter technique is commercially known as “switching mechanism at 5’ end of RNA template 
– SMART”.  
Once the first-strand cDNA synthesis is accomplished (typically for 60 min, at 37-42ºC), 
other modifying enzymes are employed, such as RNase H for introducing nicks into the 
RNA molecule of the mRNA:cDNA hybrids; E. coli DNA polymerase I for extending the 3’ 
end of RNA primers (generated by RNase H activity on mRNA moiety) and replacing the 
fragments of mRNA in the mRNA:cDNA hybrids; bacteriophage T4 DNA polymerase for 
polishing the double-stranded cDNA (ds-cDNA); and T4 polynucleotide kinase for 
phosphorylating 5’-hydroxyl groups on the ends of the ds-cDNA for ligation of linkers or 
adaptors, which is accomplished by T4 DNA ligase. Methylases (e.g., Eco RI methylase) that 
catalyze the methylation of internal cleavage sites in ds-cDNA and thus protect synthesized 
cDNA from restriction enzymes are generally used for linker-adaptor digestion in the last 
steps of preparation of cDNAs for cloning. It is interesting to note that steps of phenol-
chloroform extraction and ethanol precipitation are necessary for cleaning up the ds-cDNA 
by removing enzymes, buffers and reaction components (Ausubel et al., 1998; Sambrook 
and Russel, 2001).  
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Another important step when preparing a cDNA library is the size fractionation of cDNA 
molecules. Size exclusion chromatography (e.g., Sepharose CL-4B) is used for fractionation 
of cDNAs and allows for the elimination of linkers or adaptors, enzymes, and buffer 
components, which would be detrimental in the subsequent steps of cloning. Moreover, 
with this procedure, truncated cDNAs that arise from incomplete first- or second-strand 
cDNA synthesis are discarded and sequences >400-500 nucleotides are conveniently 
selected for construction of ‘high molecular’ weight libraries. Researchers dealing with 
venom gland cDNA libraries should note that a high number of toxins (e.g., cardiotoxin, 
crotamine-like and sarafotoxin) are encoded by short nucleotide sequences, and thus, it is 
advisable to prepare  a low molecular weight sub-library from venom gland cDNAs. As a 
rule of thumb, the step of size fractionation is accomplished after the cDNA synthesis has 
been completed and just before the ds-cDNA is cloned into a vector.  Figure 1 displays a 
typical agarose gel electrophoresis analysis of size fractionation of ds-cDNA from an animal 
venom gland.  
 
 
Fig. 1. Size fractionation of cDNA prepared with mRNAs from sea anemone (Anthopleura 
cascaia) tentacles. A doubled-stranded cDNA pool, prepared using  SMARTER technology 
according the recommended protocol (Clontech Labs), was size fractionated with a 
CHROMA Spin DEPC-400 column (bed volume = 1 ml). Aliquots of each fraction (total = 17, 
Fr-01 to Fr-17) were analyzed on a 1.0% agarose gel and visualized after ethidium bromide 
staining. Marker = 1 kb Plus ladder (Promega Corp., WI-USA). ‘cDNA’ = unfractionated 
cDNA pool. 
Both popular methods of cDNA synthesis for library construction, priming mRNA with 
an oligo(dT) adaptor and homopolymeric priming of second-strand cDNA, produce 
cDNAs for directional cloning. Thus, the choice of vectors and strategy for cDNA cloning 
is selected based on the approach for ds-cDNA synthesis. With these two methods, 
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adaptors and linkers at the 5’ and 3’ ends of cDNA molecules, containing restriction sites, 
are catalytically cleaved with two different enzymes, thereby producing cDNAs with 
distinct cohesive stick terminals. Vectors that are used for cloning cDNA include 
bacteriophage (phage) and plasmids. Today, either vector is appropriate for the 
preparation of  libraries in the range of 106 to 107 independent recombinant clones when 
high-quality phage packaging extract and high-efficiency electrocompetent E. coli are used 
for the construction of phage and plasmid cDNA libraries. Examples of vectors currently 
used are the phage-engineered plasmids (phagemids) λZAP, λZAPII and λZAP Express 
(Stratagene/Agilent Technologies, Inc., Santa Clara, CA-U.S.A.) and the plasmids 
pcDNA3.1, pDNR and pSMARTer (Clontech Laboratories, Inc., Mountain View, CA-
U.S.A.). The phagemid vectors are composed from the genomes of high-efficiency 
infectious bacteriophage particles, from which a high number of recombinant clone can be 
obtained, and allow for the in vivo recovery of plasmids harboring the inserted cDNAs. 
These vectors are commercially available either linearized or as phage arms, and the 
linear plasmid can be prepared in advance with the appropriate restriction enzymes, 
although the process of vector preparation is relatively laborious. Rádis-Baptista and 
collaborators (1999, Kassab et al., 2004, Neiva et al., 2009) have successfully prepared 
venom gland cDNA libraries in both λphage and plasmids with a high number of 
independent recombinant clones and satisfactory insert size averages. Libraries prepared 
in these ways are then amplified, and the clones are pooled or stored in microwell plates 
and maintained at -80ºC for screening.  
Several molecular biology techniques are typically employed to screen for a specific cDNA 
sequence of interest. In molecular toxinology, a convenient and practical protocol involves 
the  ‘PCR homology screening’ technique (Israel 1993; 1995; Radis-Baptista, 1999). Given that 
families of toxins have divergent members with conserved motifs, the nucleotide or amino 
acid sequences of known toxin representatives are multi-aligned, the consensus segment is 
selected, and sequence-specific oligonucleotide primers are synthesized. Hundreds of small 
aliquots from the cDNA library are separately propagated in 96-wells plates and analyzed 
by conventional PCR using a combination of gene-specific and vector primers. The pools of 
clones that are scored as positive are subdivided into a reduced number of clones per well, 
propagated, and re-screened by PCR. This iterative procedure is repeated until 100% of all 
clones in a single well score positive for the gene of interest. PCR homology screening not 
only facilitates the identification of clones of interest but also generates amplicons that can 
be easily and directly cloned for sequencing analysis. Moreover, PCR homology screening 
seems to be less laborious and tedious than screening cDNA libraries with labeled 
oligonucleotide probes, which requires replica plates, support membranes, and radioactive 
or fluorescent probes. 
As most vectors incorporate elements for functional analysis of cloned inserts, cDNAs 
from a library can be screened by detecting a biological activity as a result of recombinant 
protein expression.  However, this approach is not commonly used for screening toxin 
cDNA clones because of the low efficiency of toxin refolding in vitro, which is due to the 
high number of disulfide bonds that toxin molecules contain. Phenotype coupled to 
genotype-based screening of cDNA libraries is best achieved by alternative molecular 
techniques of protein-protein interaction, as described in the next sections. In figure 2, the 
main steps involved in the construction of cDNA and genomic DNA libraries are 
summarized. 
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Fig. 2. Overview of main steps for preparing venom gland cDNA and genomic DNA 
libraries 
2.1.2 Subtractive and genomic libraries in animal toxin research 
The subtracted cDNA library is very convenient for comparative studies of transcript 
expression. For example, when comparing the pattern of expression in venom glands of two 
distinct poisonous animals from specific geographical localities or the expression profiles of 
resting (replete) and regenerating venom glands, the production of a subtracted cDNA 
library is applicable (and recommended). The principle of subtractive cloning relies on 
nucleic acid hybridization, by which nucleotide sequences differentially expressed in one 
cell or tissue type (the tracer) are hybridized to a complementary nucleic acid pool isolated 
from the cell or tissue that is not expected to express the sequence of interest (the driver) 
(Sagerströmet al., 1997; Ausubel et al., 1998). An excess of driver, at least 10-fold higher than 
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the tracer, is prepared from the cell or tissue lacking the sequences of interest. The driver 
(also designed [-]) and tracer (bait or [+]) nucleic acid pools are hybridized, and only 
nucleotide sequences common to driver and tracer form hybrids. Driver-tracer hybrids are 
removed, and unhybridized sequences are utilized for successive rounds of subtraction for 
maximal removal of sequences that are common to both tracer and driver. The enriched 
unhybridized sequences are prepared for cloning, and the tracer-specific clones 
subsequently constitute the subtracted library. 
There are at least four strategies applied for subtractive cloning for which both DNA and 
RNA can be used as the driver and tracer. However, each subtractive cloning strategy has 
associated advantages and drawbacks, which should be considered when designing the 
experiment.  For example, it is important to consider the source and amount of material that 
will serve as the driver and tracer sequences, whether an amplification step is necessary, the 
kind of molecules that will serve as tracer (e.g., first-strand cDNA, ss-DNA or ds-DNA) and 
as driver (poly(A)+ RNA, RNA, ss-DNA or ds-DNA).  Taking these points into 
consideration, the strategy of subtraction can be chosen from the usual schemes, categorized 
as the basic PCR-based technique,  library-library hybridization and positive selection. With 
the basic subtractive cloning technique, cDNA serves as the tracer and mRNA as the driver.  
A large amount of tissue is required when performing this procedure, for which the 
subtractive hybridization can be performed only twice. With the PCR-based strategy, a 
small amount of starting material (ss-cDNA or ds-cDNA) can be used, and multiple rounds 
of subtraction are feasible. With library-library subtraction, collections of ss-cDNAs are 
used, and full-length sequences are obtained; however,  the procedure is not easy to repeat. 
In positive subtractive selection, also known as the cohesive restriction sites method, an 
excess of [-] cDNA sequences is digested with restriction enzymes to produce blunt-ended 
fragments and then mixed with sonicated [+] cDNAs. After hybridization, only clonable 
cDNAs represent the tracer-specific sequences (Sagerströmet al., 1997).  The literature 
describing the application of subtractive cloning for the investigation of differentially 
expressed genes is plentiful (for example, Lockyer et al., 2008; Zhang et al., 2008; Lefèvre 
and Murphy, 2009; Li et al., 2010; Matsumoto et al., 2011; Chengxiang et al., 2011; Liu et al., 
2011; Padmanabhan et al., 2011), while only a few examples have been reported in the field 
of molecular toxinology (Baek et al., 2009; Baek and Lee, 2010; Morgenstern et al., 2011). 
As mentioned before, another type of library typically used for studies of toxin genes is the 
genomic DNA library (Figure 2).  As with the first step in library construction, the tissue is 
surgically excised from anesthetized animals (e.g., liver from venomous animals) or cells 
(e.g., blood), which are collected from the organism of interest without killing it, and high 
molecular weight genomic DNA is then purified.  Genomic DNA inserts are then prepared 
by controlled digestion with rare cutting restriction enzymes, producing blunted-end DNA 
fragments, which are then linked to a selected vector. Vectors for cloning genomic DNA 
should have a high capacity to accommodate large fragments (in the range of 20 to 40 kb or 
more). These high-capacity vectors include, listed in order of capacity, cosmid (30-45 kb), 
bacteriophage P1 (70-100 kb), bacterial artificial chromosome, BACs (120-300 kb) and yeast 
artificial chromosomes (YACs; 0.25 to 1.2 Mb) (Ausubel et al., 1998, Sambrook and Russel, 
2001).  
Recombinant YACs are produced by digesting the vector with selected restriction enzymes 
and ligating the restriction-digested (and size-selected) genomic DNA into the left and right 
arms of the YAC vector. The YAC libraries are then transformed into yeast (Saccharomyces 
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cerevisiae) and then utilized for the genetic  screening of clones of interest. The YAC vectors 
contain restriction sites, a centromere (CEN4), an autonomously replicating sequence 
(ARS1), two selective markers, and telomeric sequences (TEL) at the vector terminus. Such 
features allow recombinant YACs to be autonomously replicated, segregate between 
daughter yeast cells and, due to their stability,  integrate into host chromosome.  
Bacterial artificial chromosomes are circular, double-stranded DNA, low copy number 
vectors derived from E. coli fertility (F) factor, a large plasmid responsible for carrying genes 
encoding proteins involved in replication, partition and conjugation.  Genetic engineered 
BACs are commercially available, and manipulation of this vector for preparing genomic 
libraries is straightforward in comparison to YAC libraries. In such cases, restriction-
digested genomic DNA fragments, selected by size, are ligated into linearized BAC vectors 
and then transformed into E. coli by electroporation. BAC libraries are then stored frozen 
until arrayed for clone screening by hybridization with oligonucleotide probes or PCR 
primers.  
Cosmids are conventional plasmids that have been engineered to allow for cloning of large 
pieces of DNA. Cosmid vectors contain one or two selectable marker (e.g., neor and ampr), a 
plasmid origin of replication (ori), restriction cloning sites, and one or two cohesive end sites 
(cos) from phage λ, which are essential for packaging of recombinant viral genome into 
infective phage particles. Restriction-digested genomic DNA and the vector are ligated, and 
the resultant linear concatenated recombinant molecules are in vitro packaged into phage 
heads. The infectious recombinant λphage injects the cosmid DNA into susceptible E. coli 
host cells, where the host’s ligase covalently join the complementary sticky ends of the 
cosmid vector, thereby producing circular molecules that replicate as plasmids. Methods of 
screening genomic DNA cosmid libraries include hybridization of colonies plated on 
membranes (replica filters) and PCR-based techniques. As cosmids are λ phage-derived 
vectors that possess high cloning efficiency and high capacity for incorporating relatively 
large DNA fragments, they represent excellent vectors for the construction of complex 
genomic DNA libraries from venomous organisms (e.g., Nobuhisa et al., 1997; Beye et al., 
1998; Fujimi et al., 2003; Rádis-Baptista et al., 2004). These libraries have been used for the 
identification of toxin genes and have led to reports describing their organization, 
comprehension of molecular evolution and diversification of toxin genes, as well as studies 
of comparisons of genomes and basic genetics.  Genomic DNA libraries of venomous 
animals also constitute real archives of a particular biological resource, by which genomic 
information can be retrieved at any time regardless of how difficult it is to find and capture 
the organism in nature.   
The first step for constructing a genomic DNA library involves the preparation of high 
molecular weight (HMW) genomic DNA. In the basic protocol, the tissues of interest are 
quickly frozen in liquid nitrogen and pulverized. The tissue powder is then transferred to a 
solution containing proteinase K and sodium dodecyl sulfate (SDS) and incubated until the 
cellular protein is completely degraded and the nucleic acid is released. The digest solution 
is extracted by phenol/chloroform/isoamyl alcohol, and the HMW genomic DNA is 
precipitated with ethanol, fished (to avoid sharing forces and DNA rupture), dried, and 
finally resuspended in aqueous buffer. Genomic DNA prepared in this manner is sufficient 
(size in the range of 100-150 kb) for cloning into phage and cosmids when precautions to 
minimize DNA degradation are taken (Ausubel et al., 1998; Sambrook and Russel, 2001). 
After purifying HMW genomic DNA, cosmid inserts are partially digested with rare cutting 
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restriction enzymes (e.g., SalI and SpeI), dephosphorylated with calf intestinal phosphatase 
(CIP), and fractionated by size using agarose gel electrophoresis. Standard agarose gels are 
convenient when separating genomic DNA fragments in the range of 0.5 to 25 kb, whereas 
pulsed-field agarose gels are required to resolve molecules ranging from 10 kb  to 2 Mb. 
Partially digested, dephosphorylated genomic DNA is ligated to cosmid arm DNA using 
bacteriophage T4 DNA ligase, and the ligated genomic DNA-cosmid vector is then 
incubated with packaging extract, which contains all proteins required to produce infectious 
λ phage. E. coli host cells are transduced with the packaged cosmids and then spread onto 
selective agar plates. The number of λ phage plaques is counted, the efficiency of cloning is 
calculated, and the average size of the inserts is analyzed by restriction endonucleases or 
agarose gel electrophoresis. In general, the efficiency of cloning is in the order or 105 to 107 
plaque forming units (pfu)/µg of genomic DNA. The genomic DNA cosmid library is 
titered by plaque dilution assay and amplified for storage. Cosmid libraries are stored in 
aliquots and preserved at -80ºC in either 7% dimethyl sulfoxide or 15-20% sterile glycerol.  
Additional information regarding the cloning of large genomic DNA fragments for 
preparation of libraries can be obtained from dedicated companies such as Agilent 
Technologies, Inc. (Santa Clara, CA-U.S.A.).  In addition to the construction of genomic 
DNA libraries, there are other simpler techniques for cloning toxin genes and examining 
their structural organization, such as direct clone by PCR-mediated amplification based on 
specific primers probes for cDNA sequences (Jiqun et al., 2004; Zhijian et al., 2006, Mao et 
al., 2007) and ‘genome (DNA) walking’ (Gendeh et al., 1997; Legros et al., 1997; Afifiyan et 
al., 1999; Jeyaseelan et al., 2003). 
2.2 Molecular techniques of protein interaction for target discovery of animal toxins 
Polypeptide toxins initially act on target cells and tissues by interacting with a particular 
biomolecule (e.g., membrane lipids, proteoglycans, ion-channels, glycoprotein and integrin 
receptors). Protein-protein interaction techniques designed to assess the association of 
proteins in mammalian cells can be used to analyze the mechanism by which toxins act to 
intoxicate organisms at the molecular (protein) level and to identify ligands with high 
specificity and selectivity for a given partner (receptor).   These techniques used for the 
identification of protein-protein interactions include the fusion of a protein of interest with 
glutathione-S-transferase (GST fusions) and analysis by far-western or pull-down (Einarson 
& Orlinick, 2002), co-immunoprecipitation and mass spectrometry-based protein 
characterization (Adams et al., 2002), yeast and bacterial two hybrid selection systems 
(Serebriiski & Joung, 2002), or phage display (Goodyear & Silverman, 2002). These represent 
robust and promising techniques for the identification of therapeutic polypeptides due to 
the direct linkage between the molecular cloning of genes (genotype) and analysis of the 
biological activity of expressed peptides and proteins (phenotype). As described by E. 
Golemis (2002), using such techniques, three types of information may be obtained: (1) the 
identification of every possible set of interacting proteins for a target (protein of interest); (2) 
the physiological significance of such interactions once partner proteins have been 
identified; and (3) the validation of the physiological role of interacting proteins with the 
systematic use of modulators. By making use of this protein-protein interaction technique, 
target-driven identification of novel animal polypeptide toxins in the context of clinical 
application is enhanced. With this technique, instead of cloning a single DNA sequence into 
a vector, which produces the bait chimera, a library of thousands of cloned DNA is best 
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suited to be scrutinized though rounds of target-driven (bait) specific binding. 
Consequently, methods used to examine protein-protein interactions are extremely 
promising for the screening of animal toxins in a customized approach, i.e., based on target-
driven selection. 
2.2.1 Phage display and its potential to interrogate animal toxin libraries 
In phage display, or peptide display, the polypeptide library of interest is fused to capsid 
protein and expressed on the surface of a bacteriophage (or phage), which becomes 
‘decorated’ with the recombinant coat protein and is therefore available for analysis of 
receptor and ligand binding. The “phage display” technology is a robust strategy used to 
identify and investigate highly specific protein-protein interactions and to find or model 
novel ligand receptors, as there is a direct physical linkage between the polypeptide 
expressed in the capsid (phenotype) and the genetic information (genotype) (Smith, 1985). 
The physical link between genetic information and recombinant protein expression in each 
single phage particle allows for iterative rounds of selection of clones with particular 
capabilities, i.e., panning, coupled with steps of amplification of a clone of interest or sub-
libraries. Rare ligand-binding clones are enriched based their specificity and rescued from 
complex libraries (over 1010 recombinant phage particles) (Goodyear & Silverman, 2001). 
Polypeptide molecules of diverse types and properties have been successfully displayed on 
the surface of filamentous phage and selected by different means. As reported by Goodyear 
and Silverman (2002), these polypeptides include enzymes (McCafferty et al., 1991), 
antibodies (McCafferty et al., 1990; Burton & Barbas, 1993; Winter et al., 1994, Zheng et al., 
2005), short peptides and protein fragments (Smith, 1985; Cwirla et al., 1990, Scott and 
Smith, 1990, Petersen et al., 1995), cytokines (Gram et al., 1993), antigens (Crameri et al., 
1994), and extracellular receptor domains (Chiswell and McCafferty, 1992; Wu et al., 1995). 
The surface display technology is also a robust molecular tool for the purpose of 
investigating the proteomic complexity of protein-protein interactions mediated by natural 
or artificial ligands. Natural ligands displayed on the phage surface include allergen 
libraries (Crameri & Walter, 1999, Crameri et al., 1994), carbohydrate and polysaccharides 
(Deng et al., 1994; Yamamoto et al., 1999), RNA binding proteins (Danner & Belasco, 2001), 
fatty acids and membrane lipids (Qiu and Marcus, 1999; Gargir et al., 2002; Nakai et al., 
2005) and ligands for Gal80p (Hertveldt et al., 2003). Moreover, phage display technology 
can be used for the identification and characterization of novel ligand receptor-binding 
interactions in studies of structure activity relationships (SARs) (Qiu et al., 1999; Li et al., 
2009; Bannister et al., 2011; Garbelli et al., 2011).  
In phage display (or peptide display) technology, segments of genes (selected or generated 
at random) or full-length cDNAs of interest are inserted in frame with a gene encoding one 
of the capsid proteins from lytic (T4, T7 or lambda phage) or non-lytic filamentous 
bacteriophages (M13, f1 or fd) (Goodyear & Silverman, 2002; Li et al., 2010).  In the case of 
filamentous phage, the adopted strategy for phage display relies on the cloning of the 
nucleotide segment encoding the peptide sequence of interest in fusion with the genes for 
one of phage capsid proteins, typically protein III or VIII (pIII and pVIII, respectively). The 
choice of the display protein, whether it be pIII, pVIII or another bacteriophage coat protein, 
will influence the panning outcome in terms of either ligand avidity or binding affinity (Qiu 
et al., 1999; Fagerlund et al., 2008). The recombinant virus genome is then packed, and the 
library proteins are expressed as fusion (chimera) capsid proteins on the phage surface. The 
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phage display library is typically screened by bait selection on immobilized supports. These 
supports include functionalized beads (chromatographic resins), multi-well plates or 
membranes, in which the bait protein is attached. As the partner protein (bait) can be 
localized in complex biological systems (cells, tissues and organs), the panning procedure 
can be performed in vivo with experimental animals as well as in vitro with isolated proteins, 
cells and tissues in culture (Michon et al., 2002; Kehoe and Kay, 2005; Valadon et al., 2006; Li 
et al., 2006; Zahid et al., 2010; Bahudhanapati et al., 2011; Kanki et al., 2011).  
Although there are numerous advantages associated with this technique, one potential 
limitation of phage display is the difficulty of correctly expressing cDNA libraries fused to 
capsid phage proteins. Technically, nucleotide-coding sequences are cloned into the 5’ end 
of capsid genes to produce virus particles decorated with heterologous proteins fused to the 
N-terminus of coat protein. However, the insertion of stop codons and unpredictable 
reading frame shifts in the fused gene constructs cause interference with coat protein 
expression and decrease the efficiency of polypeptide surface display. Strategies have been 
developed by several researchers to overcome such technical issues and improve phage 
display technology. For example, one direct alternative is to express library polypeptides at 
the carboxyl terminus of filamentous phage coat protein and avoid interruption of the 
translated chimera (Jespers et al., 1995; Hufton et al., 1999; Brunet et al., 2002). Using a 
similar strategy, fusion of cDNAs to the 5’-end of 10B gene of T7 phage allows for the 
expression of the cDNA phage display library at the C-terminus of the capsid protein 
(Danner and Belasco, 2001). Using a coupled version to produce chimeric cDNA libraries 
and coat proteins for display, Crameri and Suter (1993) prepared a phagemid vector in 
which cDNA libraries were cloned into the 3’ end of a c-Fos leucine zipper domain gene 
segment to produce polypeptide libraries fused to the carboxyl terminus of c-Fos, and the C-
jun leucine zipper domain is expressed in fusion with lambda phage pIII. As a result, during 
phage assembly, a c-Jun and c-Fos heterodimer is formed, and polypeptide libraries are 
displayed at the C-terminus of pIII. Another strategy used to display cDNA libraries, which 
was developed by Caberoy and collaborators (2009), employs a modified version of T7 
phage display. In this version, referred to as the T7Bio3C vector, a cleaved motif of human 
rhinovirus 3C protease was fused to the C-terminus of the capsid 10B protein, two GS 
flexible linkers and a biotin tag. Such vectors accommodate cDNA libraries in all three 
possible reading frames, improving the recovery of recombinant full-length cDNAs.  
Regardless of the polypeptide phage display library preparation method, panning (affinity 
selection) and clone enrichment represent critical aspects of the method.  Although some 
technical problems may arise when cloning cDNA sequences for polypeptide display on 
bacteriophage capsids, they can be potentially solved by changing the strategies of DNA 
construction, and phage display is still an efficient, sensitive and indispensable method to 
investigate the diversity of peptide molecules in natural libraries expressed in the glands of 
venomous animals. Moreover, phage display is a powerful component from the arsenal of 
functional proteomics dedicated to elucidate protein-protein interactions, novel receptor-
binding peptide ligands, and discovery of peptide drug leads, among other applications of 
protein chemistry. With such technical characteristics, the surface display technology can be 
easily adapted and automated to a array format of high-throughput screening, conditions 
that meet the productivity seen in genomic and proteomics approaches (Walter et al., 2001; 
Georgieva and Konthur, 2011) and applications in drug discovery and medicine (Sergeeva et 
al., 2006). Phage display platforms for cDNA cloning based on T7 phage biology are 
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commercially available from Novagen/EMD4Biosciences (USA), by which technical 
literature can be consulted. 
2.2.2 Yeast two hybrid system for investigating animal toxin interactions 
Another powerful molecular biology technique suitable for characterization of specific 
protein-protein interactions and potentially useful for binding studies of animal toxins and 
their cellular or tissue targets is known as the yeast two-hybrid system (Y2H). The Y2H is an 
interaction trap technology designed for the analysis of the interaction between two known 
cloned proteins of interest or to screen a library for a gene encoding an unknown protein 
that interacts with a specific known target (the bait). The system works with chimeric 
proteins, which are prepared by fusing nucleotide sequences encoding a polypeptide of 
interest (e.g., a given animal toxin) with a DNA binding domain (DBD), resulting in the 
chimera DBD-toxin on one side, and the putative partner protein (or library) and 
transcriptional activation domain (AD), generating the AD-partner on the other side. The 
fused DNA sequences coding for both constructs are co-transformed into yeast 
(Saccharomyces cerevisiae), and the chimeric proteins are then expressed and transported to 
the nucleus. When two proteins interact, the DNA binding domain and transcriptional 
activation domain are brought together and then activate the transcription of the two 
reporter genes (Serebriiski and Joung, 2002). The DBD used is the LexA protein from 
bacteria that interacts in the nucleus with lexA operators located upstream of β-galactosidase 
and LEU2 (or HIS3) genes (the first and second reporters of the system). Positive yeast two-
hybrid clones with trapped interacting protein, which are plated on selective medium 
lacking leucine (or histidine) and containing X-Gal, are identified by the blue color and are 
selected for validation. A more detailed assessment of Y2H technology can be found in 
several articles published during the last two decades (Luban and Goff, 1995; Miller and 
Stagljar 2004; Lentze and Auerbach, 2008; Ratushny and Golemis, 2008; Suter et al., 2009; 
Brückner et al., 2009; Fields et al., 2009).  Examples in the literature of yeast or bacterial two-
hybrid systems used for toxin research are still rare. Most studies in which experiments of 
interaction trap with two-hybrid systems involve toxins from organisms other than 
venomous animals, such as plant and microorganisms. For example, in wheat, a necrotizing 
toxin produced by P. tritici-repentis (Ptr ToxA) was shown to interact with a chloroplast 
protein involved in endocytosis in both ToxA-sensitive and ToxA-resistant plant cultivars 
(Manning et al., 2007).  
Using Y2H, Rádis-Baptista and collaborators (personal communication) analyzed the 
interaction of crotamine with neural protein targets. Crotamine is a low molecular weight 
cationic polypeptide found in the venom of the South American rattlesnake (Crotalus 
durissus terrificus) that, despite its toxic effect on animal tissues, has arisen as a promising 
template for drug development and biomedical applications (Kerkis et al., 2010; Radis-
Baptista, 2011). When injected i.p. into mice, crotamine causes rapid (< 10 min) and specific 
hind limb paralysis. Thus, it was first hypothesized that a neural receptor was a target of 
crotamine, thereby triggering a toxic response. To address this hypothesis, a mouse nervous 
system cDNA library was constructed into a pB42AD plasmid vector, producing fusions 
between the transcriptional activation domain (AD) and library sequences, while the bait 
DBD-crotamine fusion was cloned into a pLexA plasmid. Both plasmids were obtained from 
the MATCHMAKER LexA Two-Hybrid System (Clontech Laboratories, Inc, Mountain 
View, CA-USA). After co-transformation of a suitable yeast strain (EGY48 [p8op-lacZ]) with 
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the fusion plasmids, tests were made to ascertain that some protein partners interact. The 
preliminary results displayed that DBD-crotamine self-activated the expression of the β-
galactosidase gene reporter. Initially, this mechanism was unclear, but later, Kerkis and 
collaborators (2004, 2010) proved that crotamine was able to enter eukaryotic cells and bind 
specifically to the chromosomes, thereby validating a portion of the data obtained from the 
analysis with Y2H and crotamine.  A scheme illustrating the cloning strategy for Y2H 
screening is presented in Figure 3. 
 
 
Fig. 3. Basic steps involved in the preparation of an interaction trap assay with Y2H. 
The bacterial two-hybrid (B2H) system is analogous to the Y2H system , except that one 
polypeptide of interest (e.g., from a library) is linked to a subunit of the E. coli RNA 
polymerase (RNA pol), while the other protein of interest (for example, the bait) is fused to a 
DNA-binding domain, but the other. Similar to Y2H, when a protein-protein interaction does 
occur, the DNA-binding domain (in bait-DBD fusion) recruits a RNA pol moiety to a weak 
promoter in the host E. coli, and transcription of a reporter gene is activated, thereby indicating 
a positive interaction trap (Goodyear and Silverman, 2001; Dove and Hochschild, 2004). 
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2.2.3 In vitro display techniques for investigation of animal toxins 
One concern regarding phage display and two-hybrid systems is the involvement of living 
organisms (bacteria, phage and yeast) in the process of library preparation and selection. 
Therefore, true in vitro selection technologies have been developed by which the number of 
molecules that can be handled are not limited by cellular transformation efficiencies and 
directed protein evolution can be achieved independently of successive rounds of 
randomization (Amstutz et al., 2001). Two of these techniques are the ribosome display and 
directed evolution coupled to cDNA display. Like phage display and Y2H (or B2H), a 
physical link between genotype (RNA and DNA) and phenotype (expressed/displayed 
protein) exists in ribosome and cDNA display.  In ribosome display, non-covalent ternary 
complexes, consisting of mRNA, ribosome and nascent polypeptide, which can fold 
correctly while still attached to ribosomes, are formed, which demonstrates the coupling of 
genotype and phenotype (Hanes and Plückthum, 1997). DNA library coding for particular 
proteins of interest is transcribed in vitro. The mRNA is then purified and used for in vitro 
translation. Because the stop codon has been removed from the protein encoding sequences 
in the DNA library, the ribosome stalls at the 3’ end of the mRNA during in vitro translation, 
giving rise to a ternary complex of mRNA, ribosome, and encoded protein. In general, the 
protein is able to fold correctly on the ribosome because a carboxyl-terminal spacer had been 
genetically fused to it, thus allowing the protein of interest to fold outside of the ribosomal 
tunnel. High concentrations of magnesium and low temperature further stabilize the ternary 
complex.  These complexes, which are formed during in vitro translation, can directly be 
used to select for the properties of the displayed protein. After affinity selection and elution 
from a ligand (immobilized or in solution), the mRNA is purified, reverse-transcribed, and 
amplified by PCR. Following successive rounds of selection, which enriches the ligands at a 
rate of 100-1000-fold per cycle, the pooled DNA can be cloned in an expression vector for 
identification and large-scale preparation of selected ligand (Hanes and Plückthum, 1997; 
Amstutz et al., 2001; Schaffitzel et al., 2002). Ribosome display has been used for in vitro 
selection of biologically relevant macromolecules such as antigenic epitopes (Yau et al., 2003; 
Lee et al., 2004; Yang et al., 2007), cell-surface receptor modulators (Milovnik et al., 2009), 
and enzymes (Amstutz et al., 2006; Quinn et al., 2008). 
cDNA display is a technology similar to ribosome display in which the ternary complexes 
are formed by the covalent coupling of mRNA, bearing puromycin at the 3’ end via an 
oligonucleotide linker to the carboxyl terminus of nascent protein (Roberts and Szostak, 
1997; Nemoto et al., 1997; Miyamoto-Sato et al., 2000). In cDNA display, as seen in 
ribosome display, the DNA library coding for particular polypeptides of interest is first 
transcribed in vitro. The mRNA is purified and ligated to the puromycin linker in the 
presence of T4 RNA ligase. The mRNA-puromycin linker is then translated in a cell-free 
system (e.g., reticulocyte lysate), and when the ribosome reaches the RNA-DNA junction, 
translation stops, and the puromycin moiety enters the peptidyl transferase site of the 
ribosome, thereby allowing for the formation of a covalent link between the puromycin 
linker and the nascent polypeptide. The covalent linked polypeptide and mRNA are 
rapidly purified from the ribosome by biotin-streptavidin capture, and cDNA is 
synthesized by reverse transcription. The purified complex, composed of the hybrid 
mRNA-cDNA and polypeptide, is then ready for affinity selection using the target 
molecule of interest (Yamaguchi et al., 2009).  
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In addition to affinity selection, both technologies of ribosome and cDNA display allow for 
in vitro directed protein evolution (Yanagida et al., 2010; Dreier and Plückthun, 2011). In 
each round of selection, conventional or error-prone PCR with non-proofreading Taq 
polymerase can introduce a number of mutations and consequently increase the diversity of 
nucleotide sequences (DNA library) and displayed proteins (Cadwell and Joyce, 1992; 
Schaffitzel and Plückthun, 2001).  Recently, Naimuddin and collaborators (2011) applied 
cDNA display technology and directed protein evolution to engineer an elapidae snake 
three-finger toxin (3FTx) scaffold designed to identify modulators of interleukin-6 receptor 
(IL-6R). The three-fingers toxins are well conserved protein structures characterized by β-
sheets and three protruding loops (loops I to III) and are slightly distinct among different 
snake toxins and responsible, to a certain degree, for diverse biological activity and toxicity 
(Endo and Tamyia, 1987; Kini and Doley, 2010). Based on the work by Naimuddin and 
colleagues (2011) and previous studies (Yamaguchi et al., 2009), they were able to generate a 
3FTx library containing 1.2 x 1011 molecules by randomization of DNA sequences encoding 
all three loops of the Micrurus corallinus (coral snake) α-neurotoxin (MicTx3) as template and 
discover 3FTx-derived peptide ligand of interleukin-6 receptor. This reinforces the potential 
benefits of employing cDNA display for in vitro protein evolution and target-driven 
selection. Figure 4 depicts a schematic view of the process of cDNA display. 
 
 
Fig. 4. Depiction of the reiterative steps involved in cDNA display and main procedure for 
generating libraries for selective screening.  
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2.3 Heterologous expression of toxin genes in eukaryotic and prokaryotic systems 
Although numerous classes of polypeptide toxins identified are expressed in relatively 
minute amounts in the venom glands of several animals, milligrams of such bioactive 
molecules are required for accurate biochemical and pharmacological characterization. 
Recombinant DNA technology can be utilized to prepare vectors for cloning and 
expression of the toxin gene of interest. In most cases, the expression vectors are plasmids 
that contain promoters that direct the synthesis of large amounts of mRNA (cDNA), 
sequences that encode genetic traits that allow vector-containing cells to be selected and 
sequences that increase the efficiency with which the mRNA is translated (Ausubel et al., 
1995). For recombinant expression of proteins and polypeptide toxins, researchers can 
make use of prokaryotic and eukaryotic systems. The most utilized prokaryotic host is the 
bacteria E. coli, and the expression is directed by T7 promoters inserted into the vectors, as 
originally developed by Studier and collaborators (Studier and Moffatt, 1986; Studier et 
al., 1990). In this T7 promoter-driven system, a relatively small amount of T7 RNA 
polymerase provided from a cloned copy of T7 gene 1 is sufficient to direct high-level 
transcription from a T7 promoter in a multicopy plasmid, thereby producing the 
recombinant protein in a short amount of time (< 3 h) and in a quantity higher than 50% 
of the total cell protein. To improve the solubility of recombinant protein produced in E. 
coli and to facilitate the downstream process of purification, vectors are available that 
allow for the expression of fusion proteins, such as maltose-binding protein, glutathione-
S-transferase, hexa-histidine and thioredoxin fusions (Ausubel et al., 1995). Recombinant 
fusion proteins are easily purified by affinity chromatography, and their extra portion 
(‘tags’ and ‘carrier’ protein) can be chemically or enzymatically removed via cleavage 
signals present in the protein sequence (Sambrook and Russel, 2001). Overexpression of 
recombinant protein can be toxic and detrimental to the host bacterial cell; therefore 
insoluble intracellular aggregates, known as inclusion bodies, are often formed. These 
inclusion bodies are composed of almost pure unfolded protein, which can be properly 
refolded after disruption by different means (Marston 1986; Marston and Hartley, 1990). 
Despite the numerous parameters that have been tested to avoid IB formation, such as 
promoter strength, codon usage and gene dosage, and the temperature of induced 
expression (Martinez-Alonso et al., 2009), Garcia-Fruitos and collaborators (2005) have 
shown that overexpressed protein aggregation as inclusion bodies does not cause 
inactivation of enzymes and fluorescent proteins. Given this, when designing the 
experimental strategy, it is important to take into consideration not only the election of an 
appropriate lysis method but also the design of the necessary washing steps to isolate 
native protein and recover undisturbed active protein (Garcia-Fruitos, 2010). Prokaryotic 
expression systems are commercially available from several biotech companies, and their 
respective technical resources are easily assessed for additional information (e.g., 
EMD4Biosciences USA, Life Technologies/Invitrogen USA, GE Healthcare USA and New 
England Biolabs USA). A system that combines an insect virus (baculovirus) as a vector 
and cultured insect cells as a host has been utilized for the expression and production of 
heterologous protein. The baculovirus-insect cell system has proved to be an excellent 
choice for protein expression as it has several advantages, including the production the 
protein in high yield with the appropriate eukaryotic post-translational modifications 
(Luque and O'Reilly, 1999). The biological activity and similarity to native proteins offer a 
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great advantage over conventional bacterial expression systems (Patterson et al., 1995). 
Vectors for expression of heterologous proteins in eukaryotic cells have also been 
developed, which allow for the production of recombinant polypeptides in mammalian-
derived cells, such as African green monkey kidney fibroblast-like (COS) cells (Warren 
and Shields, 1984) and Chinese hamster ovary (CHO) cells (Cockett et al., 1990; Kaufman 
et al., 1991), budding yeast (S. cerevisiae), fission yeast (Schizosaccharomyces pombe) and 
methylotrophic yeast (Pichia pastoris) (Trueman, 1995; Gellissen and Hollenberg, 1997; Li 
et al., 2005; Takegawa et al., 2009).  A study was performed analyzing the performance of 
the five principal eukaryotic expression systems, including the stable expression of 
transfected adherent CHO cells, transient expression in mammalian COS cells, and 
baculovirus expression in invertebrate insect cells (Geisse et al., 1996). Each expression 
system has advantages and disadvantages that should be considered when selecting a 
method to prepare recombinant proteins. The expected yield, time required for 
production of the desired protein, necessity of protein refold and post-translational 
modifications, possibility of scale-up, and costs are examples of what should be taken into 
account when expressing a biologically active protein. When dealing with animal toxin, 
one should remember that most toxin families contain members with three, four or five 
disulfide bonds, which confer to each toxic polypeptide high stability and structural 
rigidity– properties that are necessary for proteins secreted into the venom. Therefore, 
systems or conditions that allow disulfide bond formation are much more advantageous.  
The successful heterologous production of animal toxin using the systems mentioned 
above has been reported. For example, with Pichia pastoris, several functional snake 
venom proteins have been expressed, such as the cystatin-like cysteine-protease inhibitors 
from the elapidae Austrelaps superbus (Richards et al., 2010); a venom P-II 
metalloproteinase (Jerdonitin) composed of metalloproteinase and disintegrin domains 
from T. jerdonii venom (Zhu et al., 2010); a thrombin-like enzyme (gloshedobin) from the 
venom of Gloydius shedaoensis in fusion with HSP-70 (Yang et al., 2009); the disintegrin 
domain of a metalloprotease from the green pit viper Trimeresurus albolabris (Singhamatr 
and Rojnuckarin, 2007); a thrombin-like enzyme (Ancrod) from the venom of Calloselasma 
rhodostoma (Yu et al., 2007); and a fibrinogenolytic serine protease from T. albolabris venom 
(Muanpasitporn and Rojnuckarin, 2007).  With bacterial expression systems, recent 
reports have described a disintegrin (r-mojastin 1) from the venom of the mohave 
rattlesnake, Crotalus scutulatus scutulatus (Sánchez et al., 2010); gloshedobin (separately 
fused at its N terminus with three fusion partners) (NusA, GST, and TrxA) (Jiang et al., 
2010); C-type lectins (BML-1 and BML-2) from the venom of Bungarus multicinctus (Lin et 
al., 2007); a c-type lectin (BJcuL) from the Bothrops jararacussu venom (Kassab et al., 2004); 
eretrin (an active spider toxin with penile erectile function) from the venom of Phoneutria 
nigriventer (Torres et al., 2010); and Huwentoxin-I, a small neurotoxin (33 amino acid in 
length) from the venom of the Chinese bird spider Ornithoctonus huwena (Che et al., 2009). 
Scorpion toxins have been expressed in baculovirus for the purpose of insect control 
(Gershburg et al., 1998; Rajendra et al., 2006). Yonamine and collaborators (2009) have 
transiently expressed a thrombin-like enzyme (gyroxin) with esterase activity from the 
venom of the South American rattlesnake C. durissus terrificus using COS-7 cells. This 
article was the first to report the functional expression of a snake toxin in a mammalian 
expression system. 
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Such works provide guidance for researchers choosing a system and using a vector to 
express a toxin of interest for the characterization of a biological activity at the molecular 
level. 
3. Conclusion 
The scientific achievements that outline the biochemical basis of the transmission of genetic 
information culminated with a revolution in Biology with the advent of Molecular Biology, 
genetic engineering (or recombinant DNA technology) and revolutionized the field of Life 
Sciences. Influenced by genetic engineering, molecular techniques have been employed in 
fields as diverse as Environmental Science and Medicine, although all these fields work 
towards common goal of improving the quality of human life. The applications of 
recombinant DNA technology range from food analysis and process to clinical diagnostics 
and therapy. The holistic view that genome, transcriptome and the other associate ‘omics’ 
(encompassing metabolome, glycome, peptidome and pharmacogenomics) are responsible 
for the characteristics of a biological system and the status of an organism in conditions of 
good health or disease has radically influenced the way we are using chemicals, including 
medicines. In addition, new disciplines have emerged from the sequential ‘revolutions’ in 
the fields of Biology as well as Systems and Synthetic Biology. Methods that are based on 
the linkage between genotype (DNA, RNA and cDNA) and phenotype (expressed 
polypeptides), which are suitable for high-throughput evaluation, have become essential for 
yielding timely results for current challenges. Therefore, gene sequence libraries prepared 
and maintained in different formats (e.g., cDNA, genomic, and subtractive) are of 
paramount significance to understand cell function and to comprehend the entire organism. 
Moreover, focusing on healthy and wealthy humans, the society (and scientific community) 
may take advantage of the information contained in such libraries with the aim of 
producing better biotechnological goods and drugs. Moreover, genotype-linked phenotype-
based libraries, such as phage/surface display, yeast and bacterial two-hybrid systems, and 
ribosome and cDNA display offer unprecedented technical capabilities to rapidly identify 
specific target-binding ligands with potential drug applications. Because polypeptides are 
involved in such interaction trap technologies, the gene (mRNA) of interest can be sub-
cloned into a given expression vector, and the (therapeutic) peptide and protein of interest 
can be prepared in sufficient amounts required for clinical research and medical practice. In 
this context, animal toxins found in nature as complex mixtures in the venom of numerous 
species of organisms inhabiting distinct geographical location and belonging to various 
biomes, constitute the ultimate biological resources for drug discovery and development. 
Families of animal toxins contain proteins that evolved for millions of years as a result of 
positive Darwinian selection (accelerated evolution), thereby generating conserved protein 
scaffolds with distinct biological and pharmacological activities. In this way, a dozen animal 
toxins have been converted either into drugs and diagnostic tools or have served as 
templates for drug design. Consequently, the combined use of refined and robust molecular 
techniques, designed to assess the biotechnological potential of venom polypeptides and 
their precursors (genes and mRNA), will offer priceless rewards concerning scientific 
endeavors in toxin research. Thus far, as presented in this chapter, the application of 
molecular cloning techniques in toxin studies can link basic research of natural compounds 
to the applied research from pharmaceutical industries, which might be ultimately 
translated into the practical scientific answers for an inquiring biological world. 
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